Cardiac Medical Devices Market in the US 2016-2020 - Increase in M&A - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Cardiac Medical Devices Market in the US 2016-2020" report to their offering.

The cardiac medical devices market in the US is expected to grow at a CAGR of 1.82% during the period 2016-2020.

The market is divided into the following segments based on product type:

• Cardiac rhythm management (CRM) devices
• Cardiac assist devices
• Heart valve

Vendors are increasingly involving in mergers and acquisitions as a business strategy to expand their operation and market share. Acquisitions of small companies by large vendors help large players increase their product portfolio.

According to the report, the market is growing due to the increased sales of cardiac rhythm management (CRM) devices. Increasing incidence and prevalence of cardiac disorders such as bradycardia, ventricular fibrillation, and tachycardia can lead to sudden cardiac arrest. To treat these patients, CRM devices are implanted that can boost the growth of the market.

Further, the report states that high cost associated with cardiac devices is hindering the growth of the market.

Key vendors:

• Boston Scientific
• LivaNova
• Medtronic
• St. Jude Medical
  

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Regulation and reimbursement scenario in US

PART 06: Market landscape

PART 07: Market segmentation by product type

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

For more information visit http://www.researchandmarkets.com/research/wzcx94/cardiac_medical